Nicholas Investment Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-128,125
Closed -$18.8M 224
2021
Q4
$18.8M Buy
128,125
+8,102
+7% +$1.19M 1.19% 14
2021
Q3
$21.2M Buy
120,023
+1,432
+1% +$253K 1.55% 8
2021
Q2
$19.2M Buy
+118,591
New +$19.2M 1.2% 28